Back to Search
Start Over
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016
- Source :
- JAMA. 318(21)
- Publication Year :
- 2017
-
Abstract
- This study uses the Drugs@FDA database to analyze clinical development times for drugs to treat serious diseases within the 4 FDA expedited programs intended to speed drug review and approval.
- Subjects :
- Drug
medicine.medical_specialty
Time Factors
business.industry
United States Food and Drug Administration
media_common.quotation_subject
MEDLINE
General Medicine
030226 pharmacology & pharmacy
United States
03 medical and health sciences
0302 clinical medicine
Drug development
medicine
Drug approval
Research Letter
Accelerated approval
030212 general & internal medicine
Intensive care medicine
business
Drug Approval
health care economics and organizations
media_common
Subjects
Details
- ISSN :
- 15383598
- Volume :
- 318
- Issue :
- 21
- Database :
- OpenAIRE
- Journal :
- JAMA
- Accession number :
- edsair.doi.dedup.....2f922e6243ff4a9c86de1bc568f1e291